#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA3399092	B	Activity of human recombinant NQO1 assessed as ratio of kcat to Km preincubated for 3 mins before NADPH addition at 0.1 to 5 umol/L by NADPH recycling assay	Homo sapiens	8		single protein format	Scientific Literature
2.	ALA3399093	F	Cytotoxicity against human A549 cells after 72 hrs by MTT assay	Homo sapiens	8		cell-based format	Scientific Literature
3.	ALA3399094	F	Cytotoxicity against human A549 cells after 72 hrs by MTT assay in presence of NQO1 inhibitor dicoumarol	Homo sapiens	8		cell-based format	Scientific Literature
4.	ALA3399095	F	Selectivity ratio of IC50 for human A549 cells in presence of NQO1 inhibitor dicoumarol to IC50 for human A549 cells	Homo sapiens	8		cell-based format	Scientific Literature
5.	ALA3399096	B	Induction of recombinant human NQO1-mediated superoxide production assessed as cytochrome c reduced per mg of NQO1 by spectrophotometric assay	Homo sapiens	2		single protein format	Scientific Literature
6.	ALA4009128	A	Substrate activity at CPR in human L02 cells assessed as CPR-mediated one-electron reduction of compound by measuring cell growth inhibition treated for 24 hrs measured after 72 hrs by MTT assay	Homo sapiens	11		cell-based format	Scientific Literature
7.	ALA4009129	U	Selectivity ratio of IC50 for substrate activity at CPR in human L02 cells assessed as cell growth inhibition to IC50 for substrate activity at NQO1 in human A549 cells assessed as cell growth inhibition	Homo sapiens	11		cell-based format	Scientific Literature
8.	ALA4009135	B	Substrate activity at recombinant human NQO1 expressed in Escherichia coli assessed as compound reduction rate by measuring NADPH consumption per umol of enzyme preincubated for 3 mins followed by NADPH addition measured for 5 mins at 2 sec time interval by UV-Visible spectroscopic method	Homo sapiens	23		assay format	Scientific Literature
9.	ALA4009136	A	Substrate activity at recombinant human CPR expressed in baculovirus infected insect cells assessed as compound reduction rate by measuring NADPH consumption per umol of enzyme preincubated for 3 mins followed by NADPH addition measured for 5 mins at 2 sec time interval by UV-Visible spectroscopic method	Homo sapiens	23		cell-based format	Scientific Literature
10.	ALA4009137	U	Selectivity ratio of compound reduction rate catalyzed by recombinant human NQO1 expressed in Escherichia coli to compound reduction rate catalyzed by recombinant human CPR expressed in baculovirus infected insect cells	Homo sapiens	23		cell-based format	Scientific Literature
11.	ALA4009138	U	Electrochemical behavior of the compound assessed as electrochemical redox potential with reference to ferrocene at 1 mM using Ag/AgCl reference electrode measured up to -2 V at potential sweep rates of 50 mV/s by cyclic voltammetry		15		assay format	Scientific Literature
12.	ALA4009139	B	Substrate activity at NQO1 in human A549 cells assessed as NQO1-mediated two-electron reduction of compound by measuring cell growth inhibition treated for 24 hrs measured after 72 hrs by MTT assay	Homo sapiens	11		cell-based format	Scientific Literature
13.	ALA5113940	F	Antiplasmodial activity against Chloroquine resistant Plasmodium falciparum FcB1 incubated for 48 hrs by SYBR green I based fluorescence assay	Plasmodium falciparum	3		organism-based format	Scientific Literature
14.	ALA5113941	F	In vivo plasmodial activity against Plasmodium berghei ANKA infected in Swiss mouse assessed as survival rate at 50 mg/kg, ip for 4 days after infection relative to control	Plasmodium berghei	2		organism-based format	Scientific Literature